(Millions of Yen / %)
| |
|
FY 2005 |
FY 2006 |
FY 2007 |
FY 2008 |
FY 2009 |
| Net Sales |
 |
23,144 |
24,353 |
27,630 |
27,207 |
27,617 |
| Overseas Sales |
 |
6,094 |
6,400 |
7,770 |
7,462 |
6,654 |
| Cost of Sales |
|
7,167 |
7,799 |
8,947 |
9,984 |
10,494 |
| Selling, General and Administrative Expenses |
|
9,075 |
10,982 |
12,005 |
12,493 |
12,012 |
| R&D Expenses |
 |
3,489 |
4,536 |
5,653 |
5,964 |
5,517 |
| Operating Income |
 |
6,901 |
5,571 |
6,676 |
4,729 |
5,110 |
| Ordinary Income |
 |
7,601 |
6,147 |
6,867 |
5,094 |
5,114 |
| Net Income |
 |
4,677 |
3,534 |
4,243 |
3,175 |
3,575 |
| Total Equity |
 |
50,693 |
52,832 |
53,646 |
52,308 |
55,426 |
| Total Assets |
 |
57,332 |
59,243 |
60,619 |
58,214 |
62,734 |
| Overseas Sales Ratio (to Net Sales) |
 |
26.3 |
26.3 |
28.1 |
27.4 |
24.1 |
| Cost of Sales Ratio(to Net Sales) |
|
31.0 |
32.0 |
32.4 |
36.7 |
38.0 |
| Selling,General and Administrative Expenses Ratio (to Net Sales) |
|
39.2 |
45.1 |
43.4 |
45.9 |
43.5 |
| R&D Expenses Ratio (to Net Sales) |
 |
15.1 |
18.6 |
20.5 |
21.9 |
20.0 |
| Operating Income Ratio (to Net Sales) |
 |
29.8 |
22.9 |
24.2 |
17.4 |
18.5 |
| Ordinary Income Ratio (to Net Sales) |
 |
32.8 |
25.2 |
24.9 |
18.7 |
18.5 |
| Net Income Ratio (to Net Sales) |
 |
20.2 |
14.5 |
15.4 |
11.7 |
12.9 |
| Return on Equity (ROE)*1 |
 |
9.6 |
6.8 |
8.0 |
6.0 |
6.6 |
| Return on Assets (ROA)*1 |
 |
14.0 |
10.5 |
11.5 |
8.6 |
8.5 |
| Turnover of Total Assets*1 |
|
0.43 |
0.42 |
0.46 |
0.46 |
0.46 |
| Shareholders'Equity Ratio |
|
88.4 |
89.2 |
88.5 |
89.9 |
88.4 |
| Number of R&D Personnel |
|
179 |
183 |
199 |
208 |
222 |
| R&D Personnel Ratio (to Total Employees) |
|
32.9 |
32.9 |
33.5 |
34.2 |
34.8 |
| Number of Employees |
|
544 |
557 |
594 |
609 |
637 |
| Amount of Capital Expenditure |
|
1,093 |
2,350 |
4,281 |
1,452 |
938 |
| Depreciation and Amortization |
|
1,194 |
1,217 |
1,225 |
2,253 |
2,716 |
| Net Income per Share |
|
79.25 |
60.93 |
73.67 |
55.68 |
62.94 |
| Average Number of Shares Outstanding*2 |
|
58,197 |
58,011 |
57,605 |
57,020 |
56,808 |
| Total Equity per Share |
|
872.71 |
910.73 |
932.83 |
920.78 |
975.68 |
| Total Common Shares Issued and Outstanding*2 |
|
58,012 |
58,011 |
57,509 |
56,808 |
56,807 |